InVivo Therapeutics adds Penn Medicine as INSPIRE study site: 4 points

InVivo Therapeutics added Philadelphia-based University of Pennsylvania as a clinical site for the INSPIRE study.

Advertisement

Here are four points:

 

1. Penn Medicine is the 20th clinical site in the INSPIRE study.

 

2. James Schuster, MD, PhD, will serve as the site’s principal investigator.

 

3. Dr. Schuster is an associate professor of neurosurgery and the associate director of the Neurocritical Care-Trauma.

 

4. The INSPIRE study tests the Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.

 

More articles on devices:
PODs under attack again: 5 key notes from the Senate Finance Committee’s report
DJO Global reports Q1 12.7% net sales growth, $38.3M net loss: 7 key notes
Camber Spine Technologies launches two new products

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.